KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

TherapeuticsMD (TXMD) Return on Equity: 2011-2025

Historic Return on Equity for TherapeuticsMD (TXMD) over the last 10 years, with Sep 2025 value amounting to 0.01%.

  • TherapeuticsMD's Return on Equity fell 2.00% to 0.01% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.01%, marking a year-over-year decrease of 2.00%. This contributed to the annual value of 0.00% for FY2024, which is 8.00% up from last year.
  • Per TherapeuticsMD's latest filing, its Return on Equity stood at 0.01% for Q3 2025, which was up 165.95% from 0.00% recorded in Q2 2025.
  • Over the past 5 years, TherapeuticsMD's Return on Equity peaked at 5.35% during Q2 2021, and registered a low of -16.90% during Q4 2022.
  • Over the past 3 years, TherapeuticsMD's median Return on Equity value was 0.00% (recorded in 2024), while the average stood at 0.46%.
  • Its Return on Equity has fluctuated over the past 5 years, first slumped by 1,795bps in 2022, then soared by 1,672bps in 2023.
  • Quarterly analysis of 5 years shows TherapeuticsMD's Return on Equity stood at 1.05% in 2021, then slumped by 1,795bps to -16.90% in 2022, then skyrocketed by 1,672bps to -0.17% in 2023, then climbed by 18bps to 0.00% in 2024, then declined by 2bps to 0.01% in 2025.
  • Its Return on Equity stands at 0.01% for Q3 2025, versus 0.00% for Q2 2025 and 0.00% for Q1 2025.